Source-grounded facts extracted from Replimune Group, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Replimune Group, Inc. amended credit facility with Hercules Capital, Inc. at greater of either (i) 8.50% and (ii) the Prime Rate (as defined in the Loan Agre.
“the interest rate was amended to be equal to the greater of either (i) 8.50% and (ii) the Prime Rate (as defined in the Loan Agreement) plus 1.75%, and the amortization date was extended from October 1, 2026 to October 1, 2027”
Replimune Group, Inc. incurred term loan of $35 million with Hercules Capital, Inc. at greater of either (i) 8.50% and (ii) the Prime Rate (as defined in the Loan Agre.
“the third loan tranche advance under the Loan Agreement was increased from $30 million to $35 million and the availability of the tranche was extended until June 15, 2026”
Replimune Group, Inc. amended Third Amendment to Loan and Security Agreement with Hercules Capital, Inc. valued at $35 million (effective 2026-01-29).
“On January 29, 2026 (the “Third Amendment Closing Date”), Replimune Group, Inc. (the “Company”) and certain subsidiaries of the Company (collectively, the “Borrowers”) entered into a Third Amendment to Loan and Security Agreement (the “Amendment”) with Hercules Capital, Inc. (“Hercules”), in its capacity as administrative agent and collateral agent (the “Agent”), and certain other financial institutions that from time to time may become parties to the Loan Agreement as lenders (collectively, the “Lenders”)”
Michael Goller was appointed as member of the Board at Replimune Group, Inc..
“appointed Michael Goller to the Board, effective immediately.”
Replimune Group, Inc. reported financial results for the fourth quarter and year ended March 31, 2024.
“Replimune Group, Inc. (the "Company") issued a news release announcing its financial results for the fourth quarter and year ended March 31, 2024”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.